McAdam LLC’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$267K Buy
981
+47
+5% +$13.4K 0.01% 365
2025
Q4
$269K Sell
934
-3
-0.3% -$838 0.01% 345
2025
Q3
$243K Sell
937
-366
-28% -$91.8K 0.01% 351
2025
Q2
$324K Buy
1,303
+105
+9% +$26K 0.02% 273
2025
Q1
$317K Sell
1,198
-277
-19% -$73.8K 0.02% 255
2024
Q4
$374K Buy
1,475
+121
+9% +$32.6K 0.02% 239
2024
Q3
$382K Sell
1,354
-218
-14% -$60.6K 0.02% 223
2024
Q2
$418K Buy
1,572
+217
+16% +$56.9K 0.03% 193
2024
Q1
$367K Buy
1,355
+48
+4% +$12.6K 0.02% 201
2023
Q4
$328K Buy
1,307
+41
+3% +$9.71K 0.02% 205
2023
Q3
$298K Buy
1,266
+49
+4% +$11.9K 0.02% 206
2023
Q2
$298K Buy
1,217
+10
+0.8% +$2.43K 0.02% 205
2023
Q1
$288K Buy
+1,207
New +$290K 0.03% 205
2018
Q4
Sell
-16
Closed -$3K 590
2018
Q3
$3K Hold
16
﹤0.01% 486
2018
Q2
$2K Hold
16
﹤0.01% 510
2018
Q1
$2K Buy
+16
New +$2.55K ﹤0.01% 572

Other funds holding VHT

McAdam LLC's VHT Position: Q1 2026 in Review

McAdam LLC increased its Vanguard Health Care ETF (VHT) stake by 5% in Q1 2026, buying an estimated $13.4K and bringing the position to 981 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #365.

McAdam LLC first reported a position in VHT in Q1 2018 and has held it in 16 quarters since. The position peaked at $418K in Q2 2024. 1,085 funds tracked by Wall St. Rank hold VHT as of Q1 2026.

  • McAdam LLC held 981 shares of Vanguard Health Care ETF worth $267K as of Q1 2026.
  • McAdam LLC bought 47 Vanguard Health Care ETF shares in Q1 2026, an estimated $13.4K.
  • Vanguard Health Care ETF made up 0.01% of McAdam LLC's portfolio in Q1 2026, its #365 holding.
  • McAdam LLC first reported a position in Vanguard Health Care ETF in Q1 2018 and has held it in 16 quarters since.
  • McAdam LLC's Vanguard Health Care ETF position peaked at $418K in Q2 2024.
  • 1,085 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q1 2026.

Based on McAdam LLC's 13F filing for Q1 2026, filed 8 May 2026.